(Q33869159)

English

Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

author name string

Roberto Canete

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Angel A Escobedo

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Maria E Gonzalez

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Pedro Almirall

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

World Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6366-6370

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Biology of Giardia lamblia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088148

5 July 2018

Treatment of giardiasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088148

5 July 2018

Giardia: overview and update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088148

5 July 2018

Activities of several benzimidazoles and tubulin inhibitors against Giardia spp. in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088148

5 July 2018

Activity of metronidazole, azithromycin and three benzimidazoles on Giardia lamblia growth and attachment to a human intestinal cell line.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088148

5 July 2018

Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088148

5 July 2018

Combined metronidazole and quinacrine hydrochloride therapy for chronic giardiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088148

5 July 2018

Failure of mebendazole treatment in Giardia lamblia infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088148

5 July 2018

Activity of the anthelmintic benzimidazoles against Giardia lamblia in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088148

5 July 2018

In-vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088148

5 July 2018

Treatment of patients with refractory giardiasis.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I39.6366

21 January 2018

Nitazoxanide: a new thiazolide antiparasitic agent

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I39.6366

21 January 2018

Comparison of chloroquine, albendazole and tinidazole in the treatment of children with giardiasis.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I39.6366

21 January 2018

Characterisation of benzimidazole binding with recombinant tubulin from Giardia duodenalis, Encephalitozoon intestinalis, and Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I39.6366

21 January 2018

Comparative clinical trial of mebendazole and metronidazole in giardiasis of children

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I39.6366

21 January 2018

A randomized trial comparing mebendazole and secnidazole for the treatment of giardiasis.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I39.6366

21 January 2018

Quinacrine-induced psychiatric disturbances in a child with common variable immunodeficiency and chronic giardiasis.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I39.6366

21 January 2018

An increase in Giardia duodenalis infection among children receiving periodic Anthelmintic treatment in Bangladesh

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088148

29 October 2018

[Effectiveness and safety of mebendazole compared to nitazoxanide in the treatment of Giardia lamblia in children]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17072963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial of mebendazole, a broad-spectrum anthelminthic

1 reference

https://pubmed.ncbi.nlm.nih.gov/17072963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of clonal growth of Giardia lamblia and Entamoeba histolytica by metronidazole, quinacrine, and other antimicrobial agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17072963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic giardiasis: studies on drug sensitivity, toxin production, and host immune response

1 reference

https://pubmed.ncbi.nlm.nih.gov/17072963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic use of mebendazole in giardial infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/17072963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mebendazole in giardial infections: confirmation of the failure of this treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17072963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/17072963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Giardia lamblia: ultrastructural study of the in vitro effect of benzimidazoles

1 reference

https://pubmed.ncbi.nlm.nih.gov/17072963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quinacrine-resistant Giardia duodenalis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17072963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alternative treatment protocols in giardiasis: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17072963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3748/WJG.V12.I39.6366

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33869159&oldid=1990248794"